Biotechnology & Life Sciences Global On demand · 24-48h

Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market Strategic Research Report

Global ELISA Kit for Antibody Detection Against African Swin…
$3,500 USD
Market Research Reports
Strategic Research Report
Global ELISA Kit for Antibody Detection Against African Swine Fever Virus Market
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Competitive ELISA, Indirect ELISA, Sandwich ELISA

By Application: Scientific Research, Veterinary Clinic, Farm, Other

Key Players: Thermo Fisher Scientific, AffiGEN, BioStone, Cusabio, BioChek, Vazyme, Elabscience, Abbexa, Biovetest, Sino-science Gene, Beijing Mingrida Science and Technology, Wuhan Keqian Biology, Zhenrui Biotech, Zhonghai Biotech, RocGene, Senkang Biotechnology, Huapai Biotechnology, ProtTech, Zhengzhou Zhongdao Biotechnology, Guosheng Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 131 pages

Overview

Scope of the Report

An ELISA kit for antibody detection against African Swine Fever Virus (ASFV) is a diagnostic tool used to identify the presence of antibodies in serum or blood samples from pigs exposed to the virus. This enzyme-linked immunosorbent assay (ELISA) method utilizes specific antigens derived from ASFV to capture and detect antibodies produced by the host immune response. The test is valuable for monitoring herd immunity, assessing vaccine efficacy, and conducting epidemiological studies.

The market for ELISA kits for antibody detection against African Swine Fever Virus (ASFV) is experiencing notable growth, driven by the rising prevalence of ASF outbreaks globally. As the disease poses a significant threat to the swine industry, there is an increasing demand for effective diagnostic tools to monitor and control its spread. Farmers, veterinarians, and regulatory bodies are prioritizing early detection and herd immunity assessments, leading to a greater reliance on ELISA kits as a reliable means to track ASFV exposure and antibody development.

Technological advancements are also influencing the ELISA kit market. Manufacturers are focusing on enhancing the sensitivity and specificity of these kits, making them more reliable for detecting antibodies in various sample types. Innovations such as improved reagents, streamlined protocols, and user-friendly formats are making these tests easier to administer and interpret. Additionally, the integration of digital platforms for data analysis and result reporting is further enhancing the usability and efficiency of ELISA kits in field settings.

Furthermore, there is a growing trend towards comprehensive disease management strategies that incorporate ELISA testing alongside other diagnostic methods. The ability to conduct multiplex assays—simultaneously detecting antibodies for ASFV and other swine pathogens—provides a more holistic view of animal health. Collaborative efforts among research institutions, private companies, and government agencies are fostering advancements in ELISA technology, ensuring that these kits remain pivotal in the ongoing battle against African Swine Fever. As awareness of ASF's impact continues to spread, the market for ELISA kits is expected to expand further, supporting swine health management initiatives worldwide.

Key Questions Addressed in this Report

What is the 10-year outlook for the global ELISA Kit for Antibody Detection Against African Swine Fever Virus market?

What factors are driving ELISA Kit for Antibody Detection Against African Swine Fever Virus market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do ELISA Kit for Antibody Detection Against African Swine Fever Virus market opportunities vary by end market size?

How does ELISA Kit for Antibody Detection Against African Swine Fever Virus break out by Type, by Application?

This report presents a comprehensive overview of the global ELISA Kit for Antibody Detection Against African Swine Fever Virus market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Competitive ELISA
  • Indirect ELISA
  • Sandwich ELISA

Segment by Application

  • Scientific Research
  • Veterinary Clinic
  • Farm
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global ELISA Kit for Antibody Detection Against African Swine Fever Virus market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Scientific Research, Veterinary Clinic, Farm evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
Competitive ELISAIndirect ELISASandwich ELISA
By Application
Scientific ResearchVeterinary ClinicFarmOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Competitive ELISA
  • 3.1.3 Indirect ELISA
  • 3.1.4 Sandwich ELISA
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Scientific Research
  • 4.1.3 Veterinary Clinic
  • 4.1.4 Farm
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 AffiGEN
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BioStone
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Cusabio
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BioChek
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Vazyme
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Elabscience
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Abbexa
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Biovetest
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Sino-science Gene
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Beijing Mingrida Science and Technology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Wuhan Keqian Biology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Zhenrui Biotech
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Zhonghai Biotech
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 RocGene
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Senkang Biotechnology
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Huapai Biotechnology
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 ProtTech
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Zhengzhou Zhongdao Biotechnology
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Guosheng Biotechnology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is ELISA Kit for Antibody Detection Against African Swine Fever Virus?
An ELISA kit for antibody detection against African Swine Fever Virus (ASFV) is a diagnostic tool used to identify the presence of antibodies in serum or blood samples from pigs exposed to the virus. This enzyme-linked immunosorbent assay (ELISA) method utilizes specific antigens derived from ASFV to capture and detect antibodies produced by the host immune response. The test is valuable for monitoring herd immunity, assessing vaccine efficacy, and conducting epidemiological studies.
How is the ELISA Kit for Antibody Detection Against African Swine Fever Virus market segmented by type?
By type, the market is segmented into Competitive ELISA, Indirect ELISA and Sandwich ELISA.
What are the key applications of ELISA Kit for Antibody Detection Against African Swine Fever Virus?
Key applications covered include Scientific Research, Veterinary Clinic, Farm and Other.
Which companies are profiled in the ELISA Kit for Antibody Detection Against African Swine Fever Virus market report?
Key players profiled include Thermo Fisher Scientific, AffiGEN, BioStone, Cusabio, BioChek, Vazyme, Elabscience and Abbexa, among 20 companies covered in total.
What geographies does the ELISA Kit for Antibody Detection Against African Swine Fever Virus market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for ELISA Kit for Antibody Detection Against African Swine Fever Virus?
The market for ELISA kits for antibody detection against African Swine Fever Virus (ASFV) is experiencing notable growth, driven by the rising prevalence of ASF outbreaks globally.
Who should buy the ELISA Kit for Antibody Detection Against African Swine Fever Virus market report?
The report is intended for manufacturers and solution providers, distributors and end users in Scientific Research, Veterinary Clinic and Farm, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the ELISA Kit for Antibody Detection Against African Swine Fever Virus market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.